Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion channels), immune checkpoint proteins and cytokines etc.?

08-16-2016 Liusong Yin, Ph.D.

Learn More

Are your peptide-based enzyme, cellular, or tissue assays failing? Is your peptide-based assay data inconsistent or non-existent?

07-19-2016 Tiffany Gupton Campolongo, Ph.D.

Learn More

Is your peptide sequence optimally designed for your unique research application? Peptide design effects the overall stability and usability of your peptide in experiments, as well as the turnaround time for your custom peptide.

07-13-2016 Tiffany Gupton Campolongo, Ph.D.

Learn More

The CRISPR/Cas9 gene editing technology is quickly becoming the most efficient tool for high-throughput functional genetic screening.

04-28-2016 Peter Dai, Ph.D., Assoclate Director

Learn More

Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR)

04-21-2016 Liusong Yin, Ph.D.

Learn More

Are you working on a Therapeutic Antibody project and considering the use of recombinant Antibodies (rAbs)? If yes, this webinar is for you.

04-07-2016 Keshav Vasanthavada

Learn More